Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
-Abuse Deterrent Formulations of opioid analgesics -Hearings related to prescription drug abuse and prevention -H.R. 5582 Abuse Deterrent Access Act of 2018
-Abuse Deterrent Formulations of opioid analgesics -Hearings related to prescription drug abuse and prevention -H.R. 5582 Abuse Deterrent Access Act of 2018 -H.R. 6 Support for Patients and Communities Act/Opioid Crisis Response Act
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
PURDUE PHARMA LP via PURDUE PHARMA, LP
2019 · fourth_quarter · 4A
Monitor issues releted to substance abuse and prevention.
Monitor issues related to substance abuse and addiction.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Source: Senate LDA
-Abuse Deterrent Formulations of opioid analgesics -Hearings related to prescription drug abuse and prevention -H.R. 5582 Abuse Deterrent Access Act of 2018 -H.R. 6 Support for Patients and Communities Act/Opioid Crisis Response Act
-Abuse Deterrent Formulations of opioid analgesics -Hearings related to prescription drug abuse and prevention -H.R. 5582 Abuse Deterrent Access Act of 2018 -H.R. 6 Support for Patients and Communities Act/Opioid Crisis Response Act
-Abuse Deterrent Formulations of opioid analgesics -Hearings related to prescription drug abuse and prevention -H.R. 5582 Abuse Deterrent Access Act of 2018 -H.R. 6 Support for Patients and Communities Act/Opioid Crisis Response Act
-Abuse Deterrent Formulations of opioid analgesics -Hearings related to prescription drug abuse and prevention -H.R. 5582 Abuse Deterrent Access Act of 2018
-Abuse Deterrent Formulations of opioid analgesics -Hearings related to prescription drug abuse and prevention -H.R. 5582 Abuse Deterrent Access Act of 2018 -H.R. 6 Support for Patients and Communities Act/Opioid Crisis Response Act
-Abuse Deterrent Formulations of opioid analgesics -Hearings related to prescription drug abuse and prevention -H.R. 5582 Abuse Deterrent Access Act of 2018 -H.R. 6 Support for Patients and Communities Act/Opioid Crisis Response Act
-Abuse Deterrent Formulations of opioid analgesics -Hearings related to prescription drug abuse and prevention -H.R. 5582 Abuse Deterrent Access Act of 2018 -H.R. 6 Support for Patients and Communities Act/Opioid Crisis Response Act
-Abuse Deterrent Formulations of opioid analgesics -Hearings related to prescription drug abuse and prevention -H.R. 5582 Abuse Deterrent Access Act of 2018 -H.R. 6 Support for Patients and Communities Act/Opioid Crisis Response Act
Comprehensive Addiction and Recovery Act of 2014
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances S.2839 - Comprehensive Addiction and Recovery Act
Comprehensive Addiction and Recovery Act of 2014
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements RiskEvaluation and MitigationStrategies for controlled substances S.2839 - Comprehensive Addiction and Recovery Act Pedigree and Supply Chain Legislation
Comprehensive Addiction and Recovery Act of 2014
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances S.2839 - Comprehensive Addiction and Recovery Act
Comprehensive Addiction and Recovery Act of 2014
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements RiskEvaluation and MitigationStrategies for controlled substances S.2839 - Comprehensive Addiction and Recovery Act Pedigree and Supply Chain Legislation
Comprehensive Addiction and Recovery Act of 2014
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements RiskEvaluation and MitigationStrategies for controlled substances S.2839 - Comprehensive Addiction and Recovery Act Pedigree and Supply Chain Legislation
Comprehensive Addiction and Recovery Act of 2014
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements RiskEvaluation and MitigationStrategies for controlled substances S.2839 - Comprehensive Addiction and Recovery Act Pedigree and Supply Chain Legislation
Comprehensive Addiction and Recovery Act of 2014
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances S.2839 - Comprehensive Addiction and Recovery Act
Comprehensive Addiction and Recovery Act of 2014
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements RiskEvaluation and MitigationStrategies for controlled substances S.2839 - Comprehensive Addiction and Recovery Act Pedigree and Supply Chain Legislation
Comprehensive Addiction and Recovery Act of 2014
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances S.2839 - Comprehensive Addiction and Recovery Act
Comprehensive Addiction and Recovery Act of 2014
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances S.2839 - Comprehensive Addiction and Recovery Act
Comprehensive Addiction and Recovery Act of 2014
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances S.2839 - Comprehensive Addiction and Recovery Act
Comprehensive Addiction and Recovery Act of 2014
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements RiskEvaluation and MitigationStrategies for controlled substances S.2839 - Comprehensive Addiction and Recovery Act Pedigree and Supply Chain Legislation
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act
Comprehensive Addiction and Recovery Act of 2014
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances S.2839 - Comprehensive Addiction and Recovery Act
Comprehensive Addiction and Recovery Act of 2014
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances S.2839 - Comprehensive Addiction and Recovery Act
Comprehensive Addiction and Recovery Act of 2014
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances S.2839 - Comprehensive Addiction and Recovery Act
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and preventionLife sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and preventionLife sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and preventionLife sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and preventionLife sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and preventionLife sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and preventionLife sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and preventionLife sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and preventionLife sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and preventionLife sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act
Stop Tampering of Prescription Pills Act of 2013
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislationPatent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 486 HR 4956 HR 6167
Stop Tampering of Prescription Pills Act of 2013
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislationPatent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 486 HR 4956 HR 6167
Stop Tampering of Prescription Pills Act of 2013
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislationPatent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 486 HR 4956 HR 6167
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislationPatent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 486 HR 4956 HR 6167
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislationPatent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 486 HR 4956 HR 6167
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislationPatent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 486 HR 4956 HR 6167
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and preventionLife sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010
Anti-counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislationPatent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010
Anti-counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislationPatent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislationPatent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010 HR 6167 STOPP Act
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislationPatent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010 HR 6167 STOPP Act
Anti-counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislationPatent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and preventionLife sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislationPatent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010 HR 6167 STOPP Act
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and preventionLife sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010
To suspend temporarily the rate of duty on Oleo Turmeric.
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Risk Evaluation and Mitigation Strategies for controlled substances HR 4956 - Stop Oxy Abuse Act HR 6169 - STOPP Act
To suspend temporarily the rate of duty on Oleo Turmeric.
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 - Stop Oxy Abuse Act
To suspend temporarily the rate of duty on Oleo Turmeric.
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Risk Evaluation and Mitigation Strategies for controlled substances HR 4956 - Stop Oxy Abuse Act HR 6169 - STOPP Act
To suspend temporarily the rate of duty on Oleo Turmeric.
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 - Stop Oxy Abuse Act
To suspend temporarily the rate of duty on Oleo Turmeric.
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 - Stop Oxy Abuse Act
To suspend temporarily the rate of duty on Oleo Turmeric.
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 - Stop Oxy Abuse Act
To suspend temporarily the rate of duty on Oleo Turmeric.
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Risk Evaluation and Mitigation Strategies for controlled substances HR 4956 - Stop Oxy Abuse Act HR 6169 - STOPP Act
To suspend temporarily the rate of duty on Oleo Turmeric.
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 - Stop Oxy Abuse Act
To suspend temporarily the rate of duty on Oleo Turmeric.
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 - Stop Oxy Abuse Act
Agricultural Disaster Assistance Act of 2012
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010 HR 6167 STOPP Act
Agricultural Disaster Assistance Act of 2012
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010 HR 6167 STOPP Act
Agricultural Disaster Assistance Act of 2012
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislationPatent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010 HR 6167 STOPP Act
Agricultural Disaster Assistance Act of 2012
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010 HR 6167 STOPP Act
Agricultural Disaster Assistance Act of 2012
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010 HR 6167 STOPP Act
Agricultural Disaster Assistance Act of 2012
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislationPatent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010 HR 6167 STOPP Act
Agricultural Disaster Assistance Act of 2012
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislationPatent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010 HR 6167 STOPP Act
Agricultural Disaster Assistance Act of 2012
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010 HR 6167 STOPP Act
Agricultural Disaster Assistance Act of 2012
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010 HR 6167 STOPP Act
Pathway to Job Creation through a Simpler, Fairer Tax Code Act of 2012
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Risk Evaluation and Mitigation Strategies for controlled substances HR 4956 - Stop Oxy Abuse Act HR 6169 - STOPP Act
Pathway to Job Creation through a Simpler, Fairer Tax Code Act of 2012
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Risk Evaluation and Mitigation Strategies for controlled substances HR 4956 - Stop Oxy Abuse Act HR 6169 - STOPP Act
Pathway to Job Creation through a Simpler, Fairer Tax Code Act of 2012
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Risk Evaluation and Mitigation Strategies for controlled substances HR 4956 - Stop Oxy Abuse Act HR 6169 - STOPP Act
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislationPatent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010 HR 6167 STOPP Act
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010 HR 6167 STOPP Act
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010 HR 6167 STOPP Act
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislationPatent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010 HR 6167 STOPP Act
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010 HR 6167 STOPP Act
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislationPatent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010 HR 6167 STOPP Act
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010 HR 6167 STOPP Act
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010 HR 6167 STOPP Act
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010 HR 6167 STOPP Act
S.27 - Preserve Access to Affordable Generics Act S.301 - Physician Payments Sunshine Act of 2009 S.319 - Pharmaceutical Market Access and Drug Safety Act of 2011 H.R.1191/S.1336 - Safe Drug Disposal Act of 2009 H.R.1260/S.515 & 610 - Patent Reform Act of 2009 H.R.1298/S.525 - Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 - Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 - Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 - Pathway for Biosimilars Act H.R.1706/S.369 - Protecting Consumer Access to Generic Drugs Act of 2009 / Preserve Access to Affordable Generics Act of 2009 H.R.3200/S.1796- America's Affordable Health Choices Act of 2009 / America's Healthy Future Act of 2009 H.R.3590 - Patient Protection and Affordable Care Act H.R.3962 - Affordable Health Care for America Act H.R.4872 - Health Care and Education Reconciliation Act of 2010 H.R.4956 - Stop Oxy Abuse Act of 2010 H.R.756/S.660 - National Pain Care Policy Act of 2009 H.R.5712 - Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 H.R.5809/S.3397 - Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 H.R.6165/S.4018 -Life Sciences Jobs and Investment Act of 2010 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
S.27 - Preserve Access to Affordable Generics Act S.301 - Physician Payments Sunshine Act of 2009 S.319 - Pharmaceutical Market Access and Drug Safety Act of 2011 H.R.1191/S.1336 - Safe Drug Disposal Act of 2009 H.R.1260/S.515 & 610 - Patent Reform Act of 2009 H.R.1298/S.525 - Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 - Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 - Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 - Pathway for Biosimilars Act H.R.1706/S.369 - Protecting Consumer Access to Generic Drugs Act of 2009 / Preserve Access to Affordable Generics Act of 2009 H.R.3200/S.1796- America's Affordable Health Choices Act of 2009 / America's Healthy Future Act of 2009 H.R.3590 - Patient Protection and Affordable Care Act H.R.3962 - Affordable Health Care for America Act H.R.4872 - Health Care and Education Reconciliation Act of 2010 H.R.4956 - Stop Oxy Abuse Act of 2010 H.R.756/S.660 - National Pain Care Policy Act of 2009 H.R.5712 - Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 H.R.5809/S.3397 - Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 H.R.6165/S.4018 -Life Sciences Jobs and Investment Act of 2010 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
S.27 - Preserve Access to Affordable Generics Act S.301 - Physician Payments Sunshine Act of 2009 S.319 - Pharmaceutical Market Access and Drug Safety Act of 2011 H.R.2 - Repealing the Job-Killing Health Care Law Act H.R.1191/S.1336 - Safe Drug Disposal Act of 2009 H.R.1249/S.23 - America Invents Act H.R.1260/S.515/S.610 - Patent Reform Act of 2009 H.R.1298/S.525 - Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 - Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 - Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 - Pathway for Biosimilars Act H.R.1706/S.369 - Protecting Consumer Access to Generic Drugs Act of 2009/Preserve Access to Affordable Generics Act of 2009 H.R.3200/S.1796 - America's Affordable Health Choices Act of 2009 / America's Healthy Future Act of 2009 H.R.3590 - Patient Protection and Affordable Care Act H.R.3962 - Affordable Health Care for America Act H.R.4872 - Health Care and Education Reconciliation Act of 2010 H.R.4956 - Stop Oxy Abuse Act of 2010 H.R.5712 - Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 H.R.5809/S.3397 - Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 H.R.6165/S.4018 - Life Sciences Jobs and Investment Act of 2010 H.R.756/S.660 - National Pain Care Policy Act of 2009 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Medical Liability Reform Orphan Drugs Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
S.27 - Preserve Access to Affordable Generics Act S.301 - Physician Payments Sunshine Act of 2009 S.319 - Pharmaceutical Market Access and Drug Safety Act of 2011 H.R.2 - Repealing the Job-Killing Health Care Law Act H.R.1191/S.1336 - Safe Drug Disposal Act of 2009 H.R.1249/S.23 - America Invents Act H.R.1260/S.515/S.610 - Patent Reform Act of 2009 H.R.1298/S.525 - Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 - Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 - Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 - Pathway for Biosimilars Act H.R.1706/S.369 - Protecting Consumer Access to Generic Drugs Act of 2009/Preserve Access to Affordable Generics Act of 2009 H.R.3200/S.1796 - America's Affordable Health Choices Act of 2009 / America's Healthy Future Act of 2009 H.R.3590 - Patient Protection and Affordable Care Act H.R.3962 - Affordable Health Care for America Act H.R.4872 - Health Care and Education Reconciliation Act of 2010 H.R.4956 - Stop Oxy Abuse Act of 2010 H.R.5712 - Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 H.R.5809/S.3397 - Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 H.R.6165/S.4018 - Life Sciences Jobs and Investment Act of 2010 H.R.756/S.660 - National Pain Care Policy Act of 2009 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Medical Liability Reform Orphan Drugs Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
S 301 - Physician Payments Sunshine Act of 2009 HR 1191/S 1336 - Safe Drug Disposal Act of 2009 HR 1260/S 515 & 610 - Patent Reform Act of 2009 HR 1298/S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 HR 1359/S 1292 - Secure and Responsible Drug Disposal Act of 2009 HR 1427/S 726 - Promoting Innovation and Access to Life-Saving Medicine Act HR 1548 - Pathway for Biosimilars Act HR 1706/S 369 - Protecting Consumer Access to Generic Drugs Act of 2009/Preserve Access to Affordable Generics Act of 2009 HR 3200/S 1796 - America's Affordable Health Choices Act of 2009 / America's Healthy Future Act of 2009 HR 3590 - Patient Protection and Affordable Care Act HR 3962 - Affordable Health Care for America Act HR 4872 - Health Care and Education Reconciliation Act of 2010 HR 4956 - Stop Oxy Abuse Act of 2010 HR 756 - National Pain Care Policy Act of 2009 HR 5712 - Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 HR 5809/S 3397 - Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 HR 6165/S 4018 - Life Sciences Jobs and Investment Act of 2010 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
S.27 - Preserve Access to Affordable Generics Act S.301 - Physician Payments Sunshine Act of 2009 S.319 - Pharmaceutical Market Access and Drug Safety Act of 2011 H.R.2 - Repealing the Job-Killing Health Care Law Act H.R.1191/S.1336 - Safe Drug Disposal Act of 2009 H.R.1249/S.23 - America Invents Act H.R.1260/S.515/S.610 - Patent Reform Act of 2009 H.R.1298/S.525 - Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 - Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 - Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 - Pathway for Biosimilars Act H.R.1706/S.369 - Protecting Consumer Access to Generic Drugs Act of 2009/Preserve Access to Affordable Generics Act of 2009 H.R.3200/S.1796 - America's Affordable Health Choices Act of 2009 / America's Healthy Future Act of 2009 H.R.3590 - Patient Protection and Affordable Care Act H.R.3962 - Affordable Health Care for America Act H.R.4872 - Health Care and Education Reconciliation Act of 2010 H.R.4956 - Stop Oxy Abuse Act of 2010 H.R.5712 - Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 H.R.5809/S.3397 - Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 H.R.6165/S.4018 - Life Sciences Jobs and Investment Act of 2010 H.R.756/S.660 - National Pain Care Policy Act of 2009 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Medical Liability Reform Orphan Drugs Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
S.27 - Preserve Access to Affordable Generics Act S.301 - Physician Payments Sunshine Act of 2009 S.319 - Pharmaceutical Market Access and Drug Safety Act of 2011 H.R.1191/S.1336 - Safe Drug Disposal Act of 2009 H.R.1260/S.515 & 610 - Patent Reform Act of 2009 H.R.1298/S.525 - Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 - Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 - Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 - Pathway for Biosimilars Act H.R.1706/S.369 - Protecting Consumer Access to Generic Drugs Act of 2009 / Preserve Access to Affordable Generics Act of 2009 H.R.3200/S.1796- America's Affordable Health Choices Act of 2009 / America's Healthy Future Act of 2009 H.R.3590 - Patient Protection and Affordable Care Act H.R.3962 - Affordable Health Care for America Act H.R.4872 - Health Care and Education Reconciliation Act of 2010 H.R.4956 - Stop Oxy Abuse Act of 2010 H.R.756/S.660 - National Pain Care Policy Act of 2009 H.R.5712 - Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 H.R.5809/S.3397 - Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 H.R.6165/S.4018 -Life Sciences Jobs and Investment Act of 2010 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
S.27 - Preserve Access to Affordable Generics Act S.301 - Physician Payments Sunshine Act of 2009 S.319 - Pharmaceutical Market Access and Drug Safety Act of 2011 H.R.2 - Repealing the Job-Killing Health Care Law Act H.R.1191/S.1336 - Safe Drug Disposal Act of 2009 H.R.1249/S.23 - America Invents Act H.R.1260/S.515/S.610 - Patent Reform Act of 2009 H.R.1298/S.525 - Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 - Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 - Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 - Pathway for Biosimilars Act H.R.1706/S.369 - Protecting Consumer Access to Generic Drugs Act of 2009/Preserve Access to Affordable Generics Act of 2009 H.R.3200/S.1796 - America's Affordable Health Choices Act of 2009 / America's Healthy Future Act of 2009 H.R.3590 - Patient Protection and Affordable Care Act H.R.3962 - Affordable Health Care for America Act H.R.4872 - Health Care and Education Reconciliation Act of 2010 H.R.4956 - Stop Oxy Abuse Act of 2010 H.R.5712 - Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 H.R.5809/S.3397 - Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 H.R.6165/S.4018 - Life Sciences Jobs and Investment Act of 2010 H.R.756/S.660 - National Pain Care Policy Act of 2009 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Medical Liability Reform Orphan Drugs Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
S 301 - Physician Payments Sunshine Act of 2009 HR 1191/S 1336 - Safe Drug Disposal Act of 2009 HR 1260/S 515 & 610 - Patent Reform Act of 2009 HR 1298/S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 HR 1359/S 1292 - Secure and Responsible Drug Disposal Act of 2009 HR 1427/S 726 - Promoting Innovation and Access to Life-Saving Medicine Act HR 1548 - Pathway for Biosimilars Act HR 1706/S 369 - Protecting Consumer Access to Generic Drugs Act of 2009/Preserve Access to Affordable Generics Act of 2009 HR 3200/S 1796 - America's Affordable Health Choices Act of 2009 / America's Healthy Future Act of 2009 HR 3590 - Patient Protection and Affordable Care Act HR 3962 - Affordable Health Care for America Act HR 4872 - Health Care and Education Reconciliation Act of 2010 HR 4956 - Stop Oxy Abuse Act of 2010 HR 756 - National Pain Care Policy Act of 2009 HR 5712 - Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 HR 5809/S 3397 - Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 HR 6165/S 4018 - Life Sciences Jobs and Investment Act of 2010 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
2019 · fourth_quarter · Q4
Monitor issues related to substance abuse and addiction.
Monitor issues releted to substance abuse and prevention.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PURDUE PHARMA LP via PURDUE PHARMA, LP
2019 · third_quarter · Q3
Monitor issues releted to substance abuse and prevention.
Monitor issues related to substance abuse and addiction.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PURDUE PHARMA LP via PURDUE PHARMA, LP
2019 · second_quarter · Q2
Monitor issues related to substance abuse and addiction.
Monitor issues releted to substance abuse and prevention.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PURDUE PHARMA LP via PURDUE PHARMA, LP
2019 · first_quarter · Q1
Monitor issues releted to substance abuse and prevention.
Monitor issues related to substance abuse and addiction.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PURDUE PHARMA LP via PURDUE PHARMA, LP
2018 · fourth_quarter · Q4
-Abuse Deterrent Formulations of opioid analgesics -Hearings related to prescription drug abuse and prevention -H.R. 5582 Abuse Deterrent Access Act of 2018 -H.R. 6 Support for Patients and Communities Act/Opioid Crisis Response Act
-Abuse Deterrent Formulations of opioid analgesics -Hearings related to prescription drug abuse and prevention -H.R. 5582 Abuse Deterrent Access Act of 2018 -H.R. 6 Support for Patients and Communities Act/Opioid Crisis Response Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PURDUE PHARMA LP via PURDUE PHARMA, LP
2018 · third_quarter · Q3
-Abuse Deterrent Formulations of opioid analgesics -Hearings related to prescription drug abuse and prevention -H.R. 5582 Abuse Deterrent Access Act of 2018 -H.R. 6 Support for Patients and Communities Act/Opioid Crisis Response Act
-Abuse Deterrent Formulations of opioid analgesics -Hearings related to prescription drug abuse and prevention -H.R. 5582 Abuse Deterrent Access Act of 2018 -H.R. 6 Support for Patients and Communities Act/Opioid Crisis Response Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PURDUE PHARMA LP via PURDUE PHARMA, LP
2018 · second_quarter · Q2
-Abuse Deterrent Formulations of opioid analgesics -Hearings related to prescription drug abuse and prevention -H.R. 5582 Abuse Deterrent Access Act of 2018
-Abuse Deterrent Formulations of opioid analgesics -Hearings related to prescription drug abuse and prevention -H.R. 5582 Abuse Deterrent Access Act of 2018
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PURDUE PHARMA LP via PURDUE PHARMA, LP
2018 · first_quarter · Q1
-Abuse Deterrent Formulations of opioid analgesics -Hearings related to prescription drug abuse and prevention
-Abuse Deterrent Formulations of opioid analgesics -Hearings related to prescription drug abuse and prevention
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PURDUE PHARMA LP via PURDUE PHARMA, LP
2017 · fourth_quarter · Q4
-Disposal of Unused Medicines -Harmonization of abuse deterrent formulations between US FDA & Health Canada -Hearings related to prescription drug abuse and prevention -Abuse Deterrent Formulation Issues
-Abuse Deterrent Formulation Issues -Patent Settlements
-Disposal of Unused Medicines -Harmonization of abuse deterrent formulations between US FDA & Health Canada -Hearings related to prescription drug abuse and prevention -Abuse Deterrent Formulation Issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PURDUE PHARMA LP via PURDUE PHARMA, LP
2017 · third_quarter · Q3
-Abuse Deterrent Formulation Issues -Patent Settlements
-Disposal of Drugs -Harmonization of abuse deterrent formulations between US FDA & Health Canada -Hearings related to prescription drug abuse and prevention -Abuse Deterrent Formulation Issues
-Disposal of Drugs -Harmonization of abuse deterrent formulations between US FDA & Health Canada -Hearings related to prescription drug abuse and prevention -Abuse Deterrent Formulation Issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PURDUE PHARMA LP via PURDUE PHARMA, LP
2017 · second_quarter · Q2
-Disposal of Drugs -Harmonization of abuse deterrent formulations between US FDA & Health Canada -Hearings related to prescription drug abuse and prevention -Abuse Deterrent Formulation Issues
-Disposal of Drugs -Harmonization of abuse deterrent formulations between US FDA & Health Canada -Hearings related to prescription drug abuse and prevention -Abuse Deterrent Formulation Issues
-Abuse Deterrent Formulation Issues -Patent Settlements
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PURDUE PHARMA LP via PURDUE PHARMA, LP
2017 · first_quarter · Q1
-Disposal of Drugs -Harmonization of abuse deterrent formulations between US FDA & Health Canada -Hearings related to prescription drug abuse and prevention -Abuse Deterrent Formulation Issues
-Disposal of Drugs -Harmonization of abuse deterrent formulations between US FDA & Health Canada -Hearings related to prescription drug abuse and prevention -Abuse Deterrent Formulation Issues
-Abuse Deterrent Formulation Issues -Patent Settlements
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PURDUE PHARMA LP via PURDUE PHARMA, LP
2016 · third_quarter · Q3
Line Extension as relates to Abuse Deterrent Formulations Patent Settlements
Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Line Extension as relates to Abuse Deterrent Formulations
Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Line Extension as relates to Abuse Deterrent Formulations
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PURDUE PHARMA LP via PURDUE PHARMA, LP
2016 · fourth_quarter · Q4
s.2839Comprehensive Addiction and Recovery Act -Line Extension as relates to Abuse Deterrent Formulations -Patent Settlements
s.2839Comprehensive Addiction and Recovery Act -Disposal of Drugs -Harmonization of abuse deterrent formulations between US FDA & Health Canada -Hearings related to prescription drug abuse and prevention -Line Extension as relates to Abuse Deterrent Formulations
Lower Passaic River EPA Remedial Design
PURDUE PHARMA LP via PURDUE PHARMA, LP
2016 · first_quarter · 1A
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements RiskEvaluation and MitigationStrategies for controlled substances S.2839 - Comprehensive Addiction and Recovery Act Pedigree and Supply Chain Legislation
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements RiskEvaluation and MitigationStrategies for controlled substances S.2839 - Comprehensive Addiction and Recovery Act Pedigree and Supply Chain Legislation
PURDUE PHARMA LP via PURDUE PHARMA, LP
2016 · second_quarter · 2A
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements RiskEvaluation and MitigationStrategies for controlled substances S.2839 - Comprehensive Addiction and Recovery Act Pedigree and Supply Chain Legislation
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements RiskEvaluation and MitigationStrategies for controlled substances S.2839 - Comprehensive Addiction and Recovery Act Pedigree and Supply Chain Legislation
PURDUE PHARMA LP via PURDUE PHARMA, LP
2016 · second_quarter · Q2
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances S.2839 - Comprehensive Addiction and Recovery Act
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances S.2839 - Comprehensive Addiction and Recovery Act
PURDUE PHARMA LP via PURDUE PHARMA, LP
2016 · first_quarter · Q1
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances S.2839 - Comprehensive Addiction and Recovery Act
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances S.2839 - Comprehensive Addiction and Recovery Act
PURDUE PHARMA LP via PURDUE PHARMA, LP
2015 · fourth_quarter · Q4
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances S.2839 - Comprehensive Addiction and Recovery Act
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances S.2839 - Comprehensive Addiction and Recovery Act
PURDUE PHARMA LP via PURDUE PHARMA, LP
2015 · second_quarter · Q2
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act
PURDUE PHARMA LP via PURDUE PHARMA, LP
2015 · third_quarter · Q3
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010
PURDUE PHARMA LP via PURDUE PHARMA, LP
2015 · first_quarter · Q1
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act
PURDUE PHARMA LP via PURDUE PHARMA, LP
2014 · fourth_quarter · Q4
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act
PURDUE PHARMA LP via PURDUE PHARMA, LP
2014 · third_quarter · Q3
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and preventionLife sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and preventionLife sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act
PURDUE PHARMA LP via PURDUE PHARMA, LP
2014 · second_quarter · Q2
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and preventionLife sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and preventionLife sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act
PURDUE PHARMA LP via PURDUE PHARMA, LP
2014 · first_quarter · Q1
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and preventionLife sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and preventionLife sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act
PURDUE PHARMA LP via PURDUE PHARMA, LP
2013 · third_quarter · Q3
Anti-counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislationPatent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010
Anti-counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislationPatent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010
PURDUE PHARMA LP via PURDUE PHARMA, LP
2013 · fourth_quarter · Q4
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and preventionLife sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and preventionLife sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010
PURDUE PHARMA LP via PURDUE PHARMA, LP
2013 · second_quarter · Q2
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislationPatent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 486 HR 4956 HR 6167
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislationPatent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 486 HR 4956 HR 6167
PURDUE PHARMA LP via PURDUE PHARMA, LP
2013 · first_quarter · Q1
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislationPatent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010 HR 6167 STOPP Act
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislationPatent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010 HR 6167 STOPP Act
PURDUE PHARMA LP via PURDUE PHARMA, LP
2012 · fourth_quarter · Q4
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislationPatent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010 HR 6167 STOPP Act
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislationPatent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010 HR 6167 STOPP Act
PURDUE PHARMA LP via PURDUE PHARMA, LP
2012 · third_quarter · Q3
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010 HR 6167 STOPP Act
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010 HR 6167 STOPP Act
PURDUE PHARMA LP via PURDUE PHARMA, LP
2012 · third_quarter · Q3
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010 HR 6167 STOPP Act
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010 HR 6167 STOPP Act
PURDUE PHARMA LP via PURDUE PHARMA, LP
2012 · second_quarter · Q2
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Risk Evaluation and Mitigation Strategies for controlled substances HR 4956 - Stop Oxy Abuse Act HR 6169 - STOPP Act
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Risk Evaluation and Mitigation Strategies for controlled substances HR 4956 - Stop Oxy Abuse Act HR 6169 - STOPP Act
PURDUE PHARMA LP via PURDUE PHARMA, LP
2012 · first_quarter · 1A
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 - Stop Oxy Abuse Act
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 - Stop Oxy Abuse Act
PURDUE PHARMA LP via PURDUE PHARMA, LP
2012 · first_quarter · Q1
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 - Stop Oxy Abuse Act
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 - Stop Oxy Abuse Act
PURDUE PHARMA LP via PURDUE PHARMA, LP
2011 · fourth_quarter · Q4
S 301 - Physician Payments Sunshine Act of 2009 HR 1191/S 1336 - Safe Drug Disposal Act of 2009 HR 1260/S 515 & 610 - Patent Reform Act of 2009 HR 1298/S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 HR 1359/S 1292 - Secure and Responsible Drug Disposal Act of 2009 HR 1427/S 726 - Promoting Innovation and Access to Life-Saving Medicine Act HR 1548 - Pathway for Biosimilars Act HR 1706/S 369 - Protecting Consumer Access to Generic Drugs Act of 2009/Preserve Access to Affordable Generics Act of 2009 HR 3200/S 1796 - America's Affordable Health Choices Act of 2009 / America's Healthy Future Act of 2009 HR 3590 - Patient Protection and Affordable Care Act HR 3962 - Affordable Health Care for America Act HR 4872 - Health Care and Education Reconciliation Act of 2010 HR 4956 - Stop Oxy Abuse Act of 2010 HR 756 - National Pain Care Policy Act of 2009 HR 5712 - Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 HR 5809/S 3397 - Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 HR 6165/S 4018 - Life Sciences Jobs and Investment Act of 2010 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
PURDUE PHARMA LP via PURDUE PHARMA, LP
2011 · second_quarter · 2A
S.27 - Preserve Access to Affordable Generics Act S.301 - Physician Payments Sunshine Act of 2009 S.319 - Pharmaceutical Market Access and Drug Safety Act of 2011 H.R.2 - Repealing the Job-Killing Health Care Law Act H.R.1191/S.1336 - Safe Drug Disposal Act of 2009 H.R.1249/S.23 - America Invents Act H.R.1260/S.515/S.610 - Patent Reform Act of 2009 H.R.1298/S.525 - Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 - Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 - Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 - Pathway for Biosimilars Act H.R.1706/S.369 - Protecting Consumer Access to Generic Drugs Act of 2009/Preserve Access to Affordable Generics Act of 2009 H.R.3200/S.1796 - America's Affordable Health Choices Act of 2009 / America's Healthy Future Act of 2009 H.R.3590 - Patient Protection and Affordable Care Act H.R.3962 - Affordable Health Care for America Act H.R.4872 - Health Care and Education Reconciliation Act of 2010 H.R.4956 - Stop Oxy Abuse Act of 2010 H.R.5712 - Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 H.R.5809/S.3397 - Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 H.R.6165/S.4018 - Life Sciences Jobs and Investment Act of 2010 H.R.756/S.660 - National Pain Care Policy Act of 2009 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Medical Liability Reform Orphan Drugs Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
PURDUE PHARMA LP via PURDUE PHARMA, LP
2011 · first_quarter · Q1
S.27 - Preserve Access to Affordable Generics Act S.301 - Physician Payments Sunshine Act of 2009 S.319 - Pharmaceutical Market Access and Drug Safety Act of 2011 H.R.1191/S.1336 - Safe Drug Disposal Act of 2009 H.R.1260/S.515 & 610 - Patent Reform Act of 2009 H.R.1298/S.525 - Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 - Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 - Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 - Pathway for Biosimilars Act H.R.1706/S.369 - Protecting Consumer Access to Generic Drugs Act of 2009 / Preserve Access to Affordable Generics Act of 2009 H.R.3200/S.1796- America's Affordable Health Choices Act of 2009 / America's Healthy Future Act of 2009 H.R.3590 - Patient Protection and Affordable Care Act H.R.3962 - Affordable Health Care for America Act H.R.4872 - Health Care and Education Reconciliation Act of 2010 H.R.4956 - Stop Oxy Abuse Act of 2010 H.R.756/S.660 - National Pain Care Policy Act of 2009 H.R.5712 - Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 H.R.5809/S.3397 - Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 H.R.6165/S.4018 -Life Sciences Jobs and Investment Act of 2010 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
PURDUE PHARMA LP via PURDUE PHARMA, LP
2010 · fourth_quarter · Q4
S.301 - Physician Payments Sunshine Act of 2009 H.R.1191/S.1336 - Safe Drug Disposal Act of 2009 H.R.1260/S.515 & 610 - Patent Reform Act of 2009 H.R.1298/S.525 - Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 - Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 - Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 - Pathway for Biosimilars Act H.R.1706/S.369 - Protecting Consumer Access to Generic Drugs Act of 2009 / Preserve Access to Affordable Generics Act of 2009 H.R.3200/S.1796- America's Affordable Health Choices Act of 2009 / America's Healthy Future Act of 2009 H.R.3590 - Patient Protection and Affordable Care Act H.R.3962 - Affordable Health Care for America Act H.R.4872 - Health Care and Education Reconciliation Act of 2010 H.R.4956 - Stop Oxy Abuse Act of 2010 H.R.756/S.660 - National Pain Care Policy Act of 2009 H.R.5712 - Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 H.R.5809/S.3397 - Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 H.R.6165/S.4018 -Life Sciences Jobs and Investment Act of 2010 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
PURDUE PHARMA LP via PURDUE PHARMA, LP
2010 · third_quarter · Q3
H.R.756/S.660 National Pain Care Policy Act of 2009 H.R.1191/S. 1336 Safe Drug Disposal Act of 2009 H.R.1260/S.515/S.610 Patent Reform Act of 2009 H.R.1298/S.525 Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 Pathway for Biosimilars Act H.R.1706 Protecting Consumer Access to Generic Drugs Act of 2009 H.R.3200 America's Affordable Health Choices Act of 2009 H.R.3590 Patient Protection and Affordable Care Act H.R.3962 Affordable Health Care for America Act H.R.4872 Health Care and Education Reconciliation Act of 2010 H.R.4956 Stop Oxy Abuse Act of 2010 H.R.5712 VeteranS', Seniors', and Children's Health Technical Corrections Act of 2010 H.R.5809/S.3397Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 H.R.6165 Life Sciences Jobs and Investment Act of 2010 S.301 Physician Payments Sunshine Act of 2009 S.369 Preserve Access to Affordable Generics Act of 2009 S.1796 America's Healthy Future Act of 2009 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
PURDUE PHARMA LP via PURDUE PHARMA, LP
2010 · second_quarter · Q2
H.R.756/S.660 National Pain Care Policy Act of 2009 H.R.1191/S. 1336 Safe Drug Disposal Act of 2009 H.R.1260/S.515/S.610 Patent Reform Act of 2009 H.R.1298/S.525 Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 Pathway for Biosimilars Act H.R.1706 Protecting Consumer Access to Generic Drugs Act of 2009 H.R.3200 America's Affordable Health Choices Act of 2009 H.R.3590 Patient Protection and Affordable Care Act H.R.3962 Affordable Health Care for America Act H.R.4872 Health Care and Education Reconciliation Act of 2010 H.R.4956 Stop Oxy Abuse Act of 2010 H.R.5712 VeteranS', Seniors', and Children's Health Technical Corrections Act of 2010 S.301 Physician Payments Sunshine Act of 2009 S.369 Preserve Access to Affordable Generics Act of 2009 S.1796 America's Healthy Future Act of 2009 SPECIFIC ISSUES Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
PURDUE PHARMA LP via PURDUE PHARMA, LP
2010 · first_quarter · Q1
H.R.756/S.660 National Pain Care Policy Act of 2009 H.R.1191/S. 1336 Safe Drug Disposal Act of 2009 H.R.1260/S.515/S.610 Patent Reform Act of 2009 H.R.1298/S.525 Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 Pathway for Biosimilars Act H.R.1706 Protecting Consumer Access to Generic Drugs Act of 2009 H.R.3200 America's Affordable Health Choices Act of 2009 H.R.3590 Patient Protection and Affordable Care Act H.R.3962 Affordable Health Care for America Act H.R.4872 Health Care and Education Reconciliation Act of 2010 H.R.4956 Stop Oxy Abuse Act of 2010 S.301 Physician Payments Sunshine Act of 2009 S.369 Preserve Access to Affordable Generics Act of 2009 S.1796 America's Healthy Future Act of 2009 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar drugs Disposal of drugs Drug reimportation Healthcare reform Hearings related to prescription drug abuse and prevention Patent settlements Pedigree legislation Prescription Drug User Fee Act reauthorization Riskevaluation and mitigationstrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
PURDUE PHARMA LP via PURDUE PHARMA, LP
2009 · fourth_quarter · Q4
HR 3200America's Affordable Health Choices Act of 2009 S 1796America's Healthy Future Act of 2009 HR 756National Pain Care Policy Act of 2009 S 660 National Pain Care Policy Act of 2009 HR 1260Patent Reform Act of 2009 S 515 Patent Reform Act of 2009 S 610 Patent Reform Act of 2009 HR 3590Patient Protection and Affordable Care Act HR 1298Pharmaceutical Market Access and Drug Safety Act of 2009 S 525 Pharmaceutical Market Access and Drug Safety Act of 2009 S 301 Physician Payments Sunshine Act of 2009 HR 1427Promoting Innovation and Access to Life-Saving Medicine Act S 726 Promoting Innovation and Access to Life-Saving Medicine Act HR 1706Protecting Consumer Access to Generic Drugs Act of 2009 S 369 Preserve Access to Affordable Generics Act of 2009 HR 1191Safe Drug Disposal Act of 2009 S 1336Safe Drug Disposal Act of 2009 HR 1359Secure and Responsible Drug Disposal Act of 2009 S 1292Secure and Responsible Drug Disposal Act of 2009 Anti- counterfeiting legislation concerning drugs Healthcare Reform Hearings related to prescription drug abuse and prevention Patent Settlements Pedigree Legislation Risk Evaluation and Mitigation Strategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
PURDUE PHARMA LP via PURDUE PHARMA, LP
2009 · third_quarter · Q3
HR 3200America's Affordable Health Choices Act of 2009 HR 756National Pain Care Policy Act of 2009 S 660National Pain Care Policy Act of 2009 HR 1260Patent Reform Act of 2009 S 515Patent Reform Act of 2009 S 610Patent Reform Act of 2009 HR 1548Pathway for Biosimilars Act HR 1298Pharmaceutical Market Access and Drug Safety Act of 2009 S 525Pharmaceutical Market Access and Drug Safety Act of 2009 S 301Physician Payments Sunshine Act of 2009 HR 1427Promoting Innovation and Access to Life-Saving Medicine Act S 726Promoting Innovation and Access to Life-Saving Medicine Act HR 1706Protecting Consumer Access to Generic Drugs Act of 2009 S 369Preserve Access to Affordable Generics Act of 2009 HR 1191Safe Drug Disposal Act of 2009 S 1336Safe Drug Disposal Act of 2009 HR 1359Secure and Responsible Drug Disposal Act of 2009 S 1292Secure and Responsible Drug Disposal Act of 2009 Anti- counterfeiting legislation concerning drugs Healthcare Reform Hearings related to prescription drug abuse and prevention Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
PURDUE PHARMA LP via PURDUE PHARMA, LP
2009 · second_quarter · Q2
H.R.756 / S.660National Pain Care Policy Act of 2009 H.R.1260 / S/515 / S.610 Patent Reform Act of 2009 S.301 Physician Payments Sunshine Act of 2009 H.R.1706 Protecting Consumer Access to Generic Drugs Act of 2009 S.369 Preserve Access to Affordable Generics Act of 2009 H.R.1191 / S.1336 Safe Drug Disposal Act of 2009 H.R.1359 / S.1292 Secure and Responsible Drug Disposal Act of 2009 Anti- counterfeiting legislation concerding drugs Healthcare Reform Hearings related to prescription drug abuse and prevention Pedigree legislation RiskEvaluation and MitigationStrategies for controlled substances
H.R.756 / S.660National Pain Care Policy Act of 2009 H.R.1260 / S/515 / S.610 Patent Reform Act of 2009 S.301 Physician Payments Sunshine Act of 2009 H.R.1706 Protecting Consumer Access to Generic Drugs Act of 2009 S.369 Preserve Access to Affordable Generics Act of 2009 H.R.1191 / S.1336 Safe Drug Disposal Act of 2009 H.R.1359 / S.1292 Secure and Responsible Drug Disposal Act of 2009 Anti- counterfeiting legislation concerding drugs Healthcare Reform Hearings related to prescription drug abuse and prevention Pedigree legislation RiskEvaluation and MitigationStrategies for controlled substances
PURDUE PHARMA LP via PURDUE PHARMA, LP
2009 · first_quarter · Q1
H.R. 756 / S.660 - National Pain Care Policy Act of 2009 H.R. 1260 / S.515 / S.610 - Patent Reform Act of 2009 H.R.1706 - Protecting Consumer Access to Generic Drugs Act of 2009 S.301 - Physician Payments Sunshine Act of 2009 S. 369 - Preserve Access to Affordable Generics Act of 2009 Hearings related to prescription drug abuse and prevention Pedigree legislation.
H.R. 756 / S.660 - National Pain Care Policy Act of 2009 H.R. 1260 / S.515 / S.610 - Patent Reform Act of 2009 H.R.1706 - Protecting Consumer Access to Generic Drugs Act of 2009 S.301 - Physician Payments Sunshine Act of 2009 S. 369 - Preserve Access to Affordable Generics Act of 2009 Hearings related to prescription drug abuse and prevention Pedigree legislation.
PURDUE PHARMA LP via PURDUE PHARMA, LP
2008 · fourth_quarter · Q4
Ryan Haight Online Pharmacy Consumer Protection Act of 2008 (H.R. 6353) Ryan Haight Online Pharmacy Consumer Protection Act of 2008 (S.980) Military Pain Care Policy Act of 2008 (H.R. 5465) National Pain Care Policy Act of 2007 (H.R. 2994) Physician Payments Sunshine Act of 2007 (S.2029) Safeguarding American's Pharmaceuticals Act (H.R. 5839) Veterans Pain Care Act (S. 2160) Hearings related to prescription drug abuse and prevention
Ryan Haight Online Pharmacy Consumer Protection Act of 2008 (H.R. 6353) Ryan Haight Online Pharmacy Consumer Protection Act of 2008 (S.980) Military Pain Care Policy Act of 2008 (H.R. 5465) National Pain Care Policy Act of 2007 (H.R. 2994) Physician Payments Sunshine Act of 2007 (S.2029) Safeguarding American's Pharmaceuticals Act (H.R. 5839) Veterans Pain Care Act (S. 2160) Hearings related to prescription drug abuse and prevention
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PURDUE PHARMA LP via PURDUE PHARMA, LP
2008 · third_quarter · Q3
Ryan Haight Online Pharmacy Consumer Protection Act of 2008 (H.R. 6353) Ryan Haight Online Pharmacy Consumer Protection Act of 2008 (S.980) Military Pain Care Policy Act of 2008 (H.R. 5465) National Pain Care Policy Act of 2007 (H.R. 2994) Physician Payments Sunshine Act of 2007 (S.2029) Safeguarding American's Pharmaceuticals Act (H.R. 5839) Veterans Pain Care Act (S. 2160) Hearings related to prescription drug abuse and prevention
Ryan Haight Online Pharmacy Consumer Protection Act of 2008 (H.R. 6353) Ryan Haight Online Pharmacy Consumer Protection Act of 2008 (S.980) Military Pain Care Policy Act of 2008 (H.R. 5465) National Pain Care Policy Act of 2007 (H.R. 2994) Physician Payments Sunshine Act of 2007 (S.2029) Safeguarding American's Pharmaceuticals Act (H.R. 5839) Veterans Pain Care Act (S. 2160) Hearings related to prescription drug abuse and prevention
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PURDUE PHARMA LP via PURDUE PHARMA, LP
2008 · second_quarter · Q2
Military Pain Care Policy Act (H.R. 5465) of 2008 National Pain Care Policy Act (H.R. 2994) of 2007 Physician Payments Sunshine Act (S.2029) of 2007 Safeguarding American's Pharmaceuticals Act (H.R. 5839) Veterans Pain Care Act (S. 2160) Hearings related to prescription drug abuse and prevention
Military Pain Care Policy Act (H.R. 5465) of 2008 National Pain Care Policy Act (H.R. 2994) of 2007 Physician Payments Sunshine Act (S.2029) of 2007 Safeguarding American's Pharmaceuticals Act (H.R. 5839) Veterans Pain Care Act (S. 2160) Hearings related to prescription drug abuse and prevention
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PURDUE PHARMA LP via PURDUE PHARMA, LP
2008 · first_quarter · Q1
National Pain Care Policy Act (H.R. 2994) of 2007 Military Pain Care Policy Act (H.R. 5465) of 2008 Veterans Pain Care Act (S. 2160) Hearings related to prescription drug abuse and prevention
National Pain Care Policy Act (H.R. 2994) of 2007 Military Pain Care Policy Act (H.R. 5465) of 2008 Veterans Pain Care Act (S. 2160) Hearings related to prescription drug abuse and prevention
National Pain Care Policy Act (H.R. 2994) of 2007 Military Pain Care Policy Act (H.R. 5465) of 2008 Veterans Pain Care Act (S. 2160) Hearings related to prescription drug abuse and prevention
PURDUE PHARMA LP via PURDUE PHARMA, LP
2007 · year_end · YA
Congressional Hearings related to: Liability Reform Prescription Drug Abuses & Prevention
Congressional Hearings related to: Liability Reform Prescription Drug Abuses & Prevention
Congressional Hearings related to: Liability Reform Prescription Drug Abuses & Prevention
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA LP via PURDUE PHARMA, LP
2007 · year_end · YY
Congressional Hearings related to: Liability Reform Prescription Drug Abuse & Prevention
Congressional Hearings related to: Liability Reform Prescription Drug Abuse & Prevention
Congressional Hearings related to: Liability Reform Prescription Drug Abuse & Prevention
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA LP via PURDUE PHARMA, LP
2007 · mid_year · MM
Congressional Hearings related to: Liability Reform Prescription Drug Abuse Prevention
Congressional Hearings related to: Liability Reform Prescription Drug Abuse Prevention
Congressional Hearings related to: Liability Reform Prescription Drug Abuse Prevention
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA LP via PURDUE PHARMA, LP
2006 · year_end · YY
Congressional Hearings related to: Liability Reform Prescription Drug Abuse Prevention
Congressional Hearings related to: Liability Reform Prescription Drug Abuse Prevention
Congressional Hearings related to: Liability Reform Prescription Drug Abuse Prevention
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA LP via PURDUE PHARMA, LP
2006 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA LP via PURDUE PHARMA, LP
2005 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA LP via PURDUE PHARMA, LP
2005 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA LP via PURDUE PHARMA, LP
2004 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA LP via PURDUE PHARMA, LP
2004 · mid_year · MA
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA LP via PURDUE PHARMA, LP
2003 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA LP via PURDUE PHARMA, LP
2003 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA LP via PURDUE PHARMA, LP
2002 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES
PURDUE PHARMA LP via PURDUE PHARMA, LP
2002 · mid_year · RR
s.2839Comprehensive Addiction and Recovery Act -Disposal of Drugs -Harmonization of abuse deterrent formulations between US FDA & Health Canada -Hearings related to prescription drug abuse and prevention -Line Extension as relates to Abuse Deterrent Formulations
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements RiskEvaluation and MitigationStrategies for controlled substances S.2839 - Comprehensive Addiction and Recovery Act Pedigree and Supply Chain Legislation
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements RiskEvaluation and MitigationStrategies for controlled substances S.2839 - Comprehensive Addiction and Recovery Act Pedigree and Supply Chain Legislation
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances S.2839 - Comprehensive Addiction and Recovery Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances S.2839 - Comprehensive Addiction and Recovery Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances S.2839 - Comprehensive Addiction and Recovery Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and preventionLife sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and preventionLife sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and preventionLife sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Anti-counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislationPatent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Harmonization of abuse deterrent formulations between US FDA & Health Canada Hearings related to prescription drug abuse and preventionLife sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislationPatent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 486 HR 4956 HR 6167
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislationPatent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010 HR 6167 STOPP Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislationPatent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010 HR 6167 STOPP Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010 HR 6167 STOPP Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 Stop Oxy Abuse Act of 2010 HR 6167 STOPP Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Risk Evaluation and Mitigation Strategies for controlled substances HR 4956 - Stop Oxy Abuse Act HR 6169 - STOPP Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 - Stop Oxy Abuse Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 - Stop Oxy Abuse Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
S 301 - Physician Payments Sunshine Act of 2009 HR 1191/S 1336 - Safe Drug Disposal Act of 2009 HR 1260/S 515 & 610 - Patent Reform Act of 2009 HR 1298/S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 HR 1359/S 1292 - Secure and Responsible Drug Disposal Act of 2009 HR 1427/S 726 - Promoting Innovation and Access to Life-Saving Medicine Act HR 1548 - Pathway for Biosimilars Act HR 1706/S 369 - Protecting Consumer Access to Generic Drugs Act of 2009/Preserve Access to Affordable Generics Act of 2009 HR 3200/S 1796 - America's Affordable Health Choices Act of 2009 / America's Healthy Future Act of 2009 HR 3590 - Patient Protection and Affordable Care Act HR 3962 - Affordable Health Care for America Act HR 4872 - Health Care and Education Reconciliation Act of 2010 HR 4956 - Stop Oxy Abuse Act of 2010 HR 756 - National Pain Care Policy Act of 2009 HR 5712 - Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 HR 5809/S 3397 - Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 HR 6165/S 4018 - Life Sciences Jobs and Investment Act of 2010 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
S 301 - Physician Payments Sunshine Act of 2009 HR 1191/S 1336 - Safe Drug Disposal Act of 2009 HR 1260/S 515 & 610 - Patent Reform Act of 2009 HR 1298/S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 HR 1359/S 1292 - Secure and Responsible Drug Disposal Act of 2009 HR 1427/S 726 - Promoting Innovation and Access to Life-Saving Medicine Act HR 1548 - Pathway for Biosimilars Act HR 1706/S 369 - Protecting Consumer Access to Generic Drugs Act of 2009/Preserve Access to Affordable Generics Act of 2009 HR 3200/S 1796 - America's Affordable Health Choices Act of 2009 / America's Healthy Future Act of 2009 HR 3590 - Patient Protection and Affordable Care Act HR 3962 - Affordable Health Care for America Act HR 4872 - Health Care and Education Reconciliation Act of 2010 HR 4956 - Stop Oxy Abuse Act of 2010 HR 756 - National Pain Care Policy Act of 2009 HR 5712 - Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 HR 5809/S 3397 - Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 HR 6165/S 4018 - Life Sciences Jobs and Investment Act of 2010 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
S 301 - Physician Payments Sunshine Act of 2009 HR 1191/S 1336 - Safe Drug Disposal Act of 2009 HR 1260/S 515 & 610 - Patent Reform Act of 2009 HR 1298/S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 HR 1359/S 1292 - Secure and Responsible Drug Disposal Act of 2009 HR 1427/S 726 - Promoting Innovation and Access to Life-Saving Medicine Act HR 1548 - Pathway for Biosimilars Act HR 1706/S 369 - Protecting Consumer Access to Generic Drugs Act of 2009/Preserve Access to Affordable Generics Act of 2009 HR 3200/S 1796 - America's Affordable Health Choices Act of 2009 / America's Healthy Future Act of 2009 HR 3590 - Patient Protection and Affordable Care Act HR 3962 - Affordable Health Care for America Act HR 4872 - Health Care and Education Reconciliation Act of 2010 HR 4956 - Stop Oxy Abuse Act of 2010 HR 756 - National Pain Care Policy Act of 2009 HR 5712 - Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 HR 5809/S 3397 - Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 HR 6165/S 4018 - Life Sciences Jobs and Investment Act of 2010 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
S.27 - Preserve Access to Affordable Generics Act S.301 - Physician Payments Sunshine Act of 2009 S.319 - Pharmaceutical Market Access and Drug Safety Act of 2011 H.R.2 - Repealing the Job-Killing Health Care Law Act H.R.1191/S.1336 - Safe Drug Disposal Act of 2009 H.R.1249/S.23 - America Invents Act H.R.1260/S.515/S.610 - Patent Reform Act of 2009 H.R.1298/S.525 - Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 - Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 - Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 - Pathway for Biosimilars Act H.R.1706/S.369 - Protecting Consumer Access to Generic Drugs Act of 2009/Preserve Access to Affordable Generics Act of 2009 H.R.3200/S.1796 - America's Affordable Health Choices Act of 2009 / America's Healthy Future Act of 2009 H.R.3590 - Patient Protection and Affordable Care Act H.R.3962 - Affordable Health Care for America Act H.R.4872 - Health Care and Education Reconciliation Act of 2010 H.R.4956 - Stop Oxy Abuse Act of 2010 H.R.5712 - Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 H.R.5809/S.3397 - Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 H.R.6165/S.4018 - Life Sciences Jobs and Investment Act of 2010 H.R.756/S.660 - National Pain Care Policy Act of 2009 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Medical Liability Reform Orphan Drugs Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
S.27 - Preserve Access to Affordable Generics Act S.301 - Physician Payments Sunshine Act of 2009 S.319 - Pharmaceutical Market Access and Drug Safety Act of 2011 H.R.2 - Repealing the Job-Killing Health Care Law Act H.R.1191/S.1336 - Safe Drug Disposal Act of 2009 H.R.1249/S.23 - America Invents Act H.R.1260/S.515/S.610 - Patent Reform Act of 2009 H.R.1298/S.525 - Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 - Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 - Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 - Pathway for Biosimilars Act H.R.1706/S.369 - Protecting Consumer Access to Generic Drugs Act of 2009/Preserve Access to Affordable Generics Act of 2009 H.R.3200/S.1796 - America's Affordable Health Choices Act of 2009 / America's Healthy Future Act of 2009 H.R.3590 - Patient Protection and Affordable Care Act H.R.3962 - Affordable Health Care for America Act H.R.4872 - Health Care and Education Reconciliation Act of 2010 H.R.4956 - Stop Oxy Abuse Act of 2010 H.R.5712 - Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 H.R.5809/S.3397 - Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 H.R.6165/S.4018 - Life Sciences Jobs and Investment Act of 2010 H.R.756/S.660 - National Pain Care Policy Act of 2009 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Medical Liability Reform Orphan Drugs Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
S.27 - Preserve Access to Affordable Generics Act S.301 - Physician Payments Sunshine Act of 2009 S.319 - Pharmaceutical Market Access and Drug Safety Act of 2011 H.R.2 - Repealing the Job-Killing Health Care Law Act H.R.1191/S.1336 - Safe Drug Disposal Act of 2009 H.R.1249/S.23 - America Invents Act H.R.1260/S.515/S.610 - Patent Reform Act of 2009 H.R.1298/S.525 - Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 - Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 - Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 - Pathway for Biosimilars Act H.R.1706/S.369 - Protecting Consumer Access to Generic Drugs Act of 2009/Preserve Access to Affordable Generics Act of 2009 H.R.3200/S.1796 - America's Affordable Health Choices Act of 2009 / America's Healthy Future Act of 2009 H.R.3590 - Patient Protection and Affordable Care Act H.R.3962 - Affordable Health Care for America Act H.R.4872 - Health Care and Education Reconciliation Act of 2010 H.R.4956 - Stop Oxy Abuse Act of 2010 H.R.5712 - Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 H.R.5809/S.3397 - Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 H.R.6165/S.4018 - Life Sciences Jobs and Investment Act of 2010 H.R.756/S.660 - National Pain Care Policy Act of 2009 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Medical Liability Reform Orphan Drugs Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
S.27 - Preserve Access to Affordable Generics Act S.301 - Physician Payments Sunshine Act of 2009 S.319 - Pharmaceutical Market Access and Drug Safety Act of 2011 H.R.1191/S.1336 - Safe Drug Disposal Act of 2009 H.R.1260/S.515 & 610 - Patent Reform Act of 2009 H.R.1298/S.525 - Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 - Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 - Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 - Pathway for Biosimilars Act H.R.1706/S.369 - Protecting Consumer Access to Generic Drugs Act of 2009 / Preserve Access to Affordable Generics Act of 2009 H.R.3200/S.1796- America's Affordable Health Choices Act of 2009 / America's Healthy Future Act of 2009 H.R.3590 - Patient Protection and Affordable Care Act H.R.3962 - Affordable Health Care for America Act H.R.4872 - Health Care and Education Reconciliation Act of 2010 H.R.4956 - Stop Oxy Abuse Act of 2010 H.R.756/S.660 - National Pain Care Policy Act of 2009 H.R.5712 - Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 H.R.5809/S.3397 - Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 H.R.6165/S.4018 -Life Sciences Jobs and Investment Act of 2010 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
S.27 - Preserve Access to Affordable Generics Act S.301 - Physician Payments Sunshine Act of 2009 S.319 - Pharmaceutical Market Access and Drug Safety Act of 2011 H.R.1191/S.1336 - Safe Drug Disposal Act of 2009 H.R.1260/S.515 & 610 - Patent Reform Act of 2009 H.R.1298/S.525 - Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 - Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 - Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 - Pathway for Biosimilars Act H.R.1706/S.369 - Protecting Consumer Access to Generic Drugs Act of 2009 / Preserve Access to Affordable Generics Act of 2009 H.R.3200/S.1796- America's Affordable Health Choices Act of 2009 / America's Healthy Future Act of 2009 H.R.3590 - Patient Protection and Affordable Care Act H.R.3962 - Affordable Health Care for America Act H.R.4872 - Health Care and Education Reconciliation Act of 2010 H.R.4956 - Stop Oxy Abuse Act of 2010 H.R.756/S.660 - National Pain Care Policy Act of 2009 H.R.5712 - Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 H.R.5809/S.3397 - Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 H.R.6165/S.4018 -Life Sciences Jobs and Investment Act of 2010 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
S.27 - Preserve Access to Affordable Generics Act S.301 - Physician Payments Sunshine Act of 2009 S.319 - Pharmaceutical Market Access and Drug Safety Act of 2011 H.R.1191/S.1336 - Safe Drug Disposal Act of 2009 H.R.1260/S.515 & 610 - Patent Reform Act of 2009 H.R.1298/S.525 - Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 - Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 - Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 - Pathway for Biosimilars Act H.R.1706/S.369 - Protecting Consumer Access to Generic Drugs Act of 2009 / Preserve Access to Affordable Generics Act of 2009 H.R.3200/S.1796- America's Affordable Health Choices Act of 2009 / America's Healthy Future Act of 2009 H.R.3590 - Patient Protection and Affordable Care Act H.R.3962 - Affordable Health Care for America Act H.R.4872 - Health Care and Education Reconciliation Act of 2010 H.R.4956 - Stop Oxy Abuse Act of 2010 H.R.756/S.660 - National Pain Care Policy Act of 2009 H.R.5712 - Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 H.R.5809/S.3397 - Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 H.R.6165/S.4018 -Life Sciences Jobs and Investment Act of 2010 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
S.301 - Physician Payments Sunshine Act of 2009 H.R.1191/S.1336 - Safe Drug Disposal Act of 2009 H.R.1260/S.515 & 610 - Patent Reform Act of 2009 H.R.1298/S.525 - Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 - Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 - Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 - Pathway for Biosimilars Act H.R.1706/S.369 - Protecting Consumer Access to Generic Drugs Act of 2009 / Preserve Access to Affordable Generics Act of 2009 H.R.3200/S.1796- America's Affordable Health Choices Act of 2009 / America's Healthy Future Act of 2009 H.R.3590 - Patient Protection and Affordable Care Act H.R.3962 - Affordable Health Care for America Act H.R.4872 - Health Care and Education Reconciliation Act of 2010 H.R.4956 - Stop Oxy Abuse Act of 2010 H.R.756/S.660 - National Pain Care Policy Act of 2009 H.R.5712 - Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 H.R.5809/S.3397 - Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 H.R.6165/S.4018 -Life Sciences Jobs and Investment Act of 2010 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
S.301 - Physician Payments Sunshine Act of 2009 H.R.1191/S.1336 - Safe Drug Disposal Act of 2009 H.R.1260/S.515 & 610 - Patent Reform Act of 2009 H.R.1298/S.525 - Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 - Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 - Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 - Pathway for Biosimilars Act H.R.1706/S.369 - Protecting Consumer Access to Generic Drugs Act of 2009 / Preserve Access to Affordable Generics Act of 2009 H.R.3200/S.1796- America's Affordable Health Choices Act of 2009 / America's Healthy Future Act of 2009 H.R.3590 - Patient Protection and Affordable Care Act H.R.3962 - Affordable Health Care for America Act H.R.4872 - Health Care and Education Reconciliation Act of 2010 H.R.4956 - Stop Oxy Abuse Act of 2010 H.R.756/S.660 - National Pain Care Policy Act of 2009 H.R.5712 - Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 H.R.5809/S.3397 - Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 H.R.6165/S.4018 -Life Sciences Jobs and Investment Act of 2010 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
S.301 - Physician Payments Sunshine Act of 2009 H.R.1191/S.1336 - Safe Drug Disposal Act of 2009 H.R.1260/S.515 & 610 - Patent Reform Act of 2009 H.R.1298/S.525 - Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 - Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 - Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 - Pathway for Biosimilars Act H.R.1706/S.369 - Protecting Consumer Access to Generic Drugs Act of 2009 / Preserve Access to Affordable Generics Act of 2009 H.R.3200/S.1796- America's Affordable Health Choices Act of 2009 / America's Healthy Future Act of 2009 H.R.3590 - Patient Protection and Affordable Care Act H.R.3962 - Affordable Health Care for America Act H.R.4872 - Health Care and Education Reconciliation Act of 2010 H.R.4956 - Stop Oxy Abuse Act of 2010 H.R.756/S.660 - National Pain Care Policy Act of 2009 H.R.5712 - Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 H.R.5809/S.3397 - Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 H.R.6165/S.4018 -Life Sciences Jobs and Investment Act of 2010 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
H.R.756/S.660 National Pain Care Policy Act of 2009 H.R.1191/S. 1336 Safe Drug Disposal Act of 2009 H.R.1260/S.515/S.610 Patent Reform Act of 2009 H.R.1298/S.525 Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 Pathway for Biosimilars Act H.R.1706 Protecting Consumer Access to Generic Drugs Act of 2009 H.R.3200 America's Affordable Health Choices Act of 2009 H.R.3590 Patient Protection and Affordable Care Act H.R.3962 Affordable Health Care for America Act H.R.4872 Health Care and Education Reconciliation Act of 2010 H.R.4956 Stop Oxy Abuse Act of 2010 H.R.5712 VeteranS', Seniors', and Children's Health Technical Corrections Act of 2010 H.R.5809/S.3397Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 H.R.6165 Life Sciences Jobs and Investment Act of 2010 S.301 Physician Payments Sunshine Act of 2009 S.369 Preserve Access to Affordable Generics Act of 2009 S.1796 America's Healthy Future Act of 2009 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
H.R.756/S.660 National Pain Care Policy Act of 2009 H.R.1191/S. 1336 Safe Drug Disposal Act of 2009 H.R.1260/S.515/S.610 Patent Reform Act of 2009 H.R.1298/S.525 Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 Pathway for Biosimilars Act H.R.1706 Protecting Consumer Access to Generic Drugs Act of 2009 H.R.3200 America's Affordable Health Choices Act of 2009 H.R.3590 Patient Protection and Affordable Care Act H.R.3962 Affordable Health Care for America Act H.R.4872 Health Care and Education Reconciliation Act of 2010 H.R.4956 Stop Oxy Abuse Act of 2010 H.R.5712 VeteranS', Seniors', and Children's Health Technical Corrections Act of 2010 H.R.5809/S.3397Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 H.R.6165 Life Sciences Jobs and Investment Act of 2010 S.301 Physician Payments Sunshine Act of 2009 S.369 Preserve Access to Affordable Generics Act of 2009 S.1796 America's Healthy Future Act of 2009 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
H.R.756/S.660 National Pain Care Policy Act of 2009 H.R.1191/S. 1336 Safe Drug Disposal Act of 2009 H.R.1260/S.515/S.610 Patent Reform Act of 2009 H.R.1298/S.525 Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 Pathway for Biosimilars Act H.R.1706 Protecting Consumer Access to Generic Drugs Act of 2009 H.R.3200 America's Affordable Health Choices Act of 2009 H.R.3590 Patient Protection and Affordable Care Act H.R.3962 Affordable Health Care for America Act H.R.4872 Health Care and Education Reconciliation Act of 2010 H.R.4956 Stop Oxy Abuse Act of 2010 H.R.5712 VeteranS', Seniors', and Children's Health Technical Corrections Act of 2010 H.R.5809/S.3397Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 H.R.6165 Life Sciences Jobs and Investment Act of 2010 S.301 Physician Payments Sunshine Act of 2009 S.369 Preserve Access to Affordable Generics Act of 2009 S.1796 America's Healthy Future Act of 2009 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
H.R.756/S.660 National Pain Care Policy Act of 2009 H.R.1191/S. 1336 Safe Drug Disposal Act of 2009 H.R.1260/S.515/S.610 Patent Reform Act of 2009 H.R.1298/S.525 Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 Pathway for Biosimilars Act H.R.1706 Protecting Consumer Access to Generic Drugs Act of 2009 H.R.3200 America's Affordable Health Choices Act of 2009 H.R.3590 Patient Protection and Affordable Care Act H.R.3962 Affordable Health Care for America Act H.R.4872 Health Care and Education Reconciliation Act of 2010 H.R.4956 Stop Oxy Abuse Act of 2010 H.R.5712 VeteranS', Seniors', and Children's Health Technical Corrections Act of 2010 S.301 Physician Payments Sunshine Act of 2009 S.369 Preserve Access to Affordable Generics Act of 2009 S.1796 America's Healthy Future Act of 2009 SPECIFIC ISSUES Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
H.R.756/S.660 National Pain Care Policy Act of 2009 H.R.1191/S. 1336 Safe Drug Disposal Act of 2009 H.R.1260/S.515/S.610 Patent Reform Act of 2009 H.R.1298/S.525 Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 Pathway for Biosimilars Act H.R.1706 Protecting Consumer Access to Generic Drugs Act of 2009 H.R.3200 America's Affordable Health Choices Act of 2009 H.R.3590 Patient Protection and Affordable Care Act H.R.3962 Affordable Health Care for America Act H.R.4872 Health Care and Education Reconciliation Act of 2010 H.R.4956 Stop Oxy Abuse Act of 2010 H.R.5712 VeteranS', Seniors', and Children's Health Technical Corrections Act of 2010 S.301 Physician Payments Sunshine Act of 2009 S.369 Preserve Access to Affordable Generics Act of 2009 S.1796 America's Healthy Future Act of 2009 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
H.R.756/S.660 National Pain Care Policy Act of 2009 H.R.1191/S. 1336 Safe Drug Disposal Act of 2009 H.R.1260/S.515/S.610 Patent Reform Act of 2009 H.R.1298/S.525 Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 Pathway for Biosimilars Act H.R.1706 Protecting Consumer Access to Generic Drugs Act of 2009 H.R.3200 America's Affordable Health Choices Act of 2009 H.R.3590 Patient Protection and Affordable Care Act H.R.3962 Affordable Health Care for America Act H.R.4872 Health Care and Education Reconciliation Act of 2010 H.R.4956 Stop Oxy Abuse Act of 2010 H.R.5712 VeteranS', Seniors', and Children's Health Technical Corrections Act of 2010 S.301 Physician Payments Sunshine Act of 2009 S.369 Preserve Access to Affordable Generics Act of 2009 S.1796 America's Healthy Future Act of 2009 SPECIFIC ISSUES Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
H.R.756/S.660 National Pain Care Policy Act of 2009 H.R.1191/S. 1336 Safe Drug Disposal Act of 2009 H.R.1260/S.515/S.610 Patent Reform Act of 2009 H.R.1298/S.525 Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 Pathway for Biosimilars Act H.R.1706 Protecting Consumer Access to Generic Drugs Act of 2009 H.R.3200 America's Affordable Health Choices Act of 2009 H.R.3590 Patient Protection and Affordable Care Act H.R.3962 Affordable Health Care for America Act H.R.4872 Health Care and Education Reconciliation Act of 2010 H.R.4956 Stop Oxy Abuse Act of 2010 S.301 Physician Payments Sunshine Act of 2009 S.369 Preserve Access to Affordable Generics Act of 2009 S.1796 America's Healthy Future Act of 2009 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar drugs Disposal of drugs Drug reimportation Healthcare reform Hearings related to prescription drug abuse and prevention Patent settlements Pedigree legislation Prescription Drug User Fee Act reauthorization Riskevaluation and mitigationstrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
H.R.756/S.660 National Pain Care Policy Act of 2009 H.R.1191/S. 1336 Safe Drug Disposal Act of 2009 H.R.1260/S.515/S.610 Patent Reform Act of 2009 H.R.1298/S.525 Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 Pathway for Biosimilars Act H.R.1706 Protecting Consumer Access to Generic Drugs Act of 2009 H.R.3200 America's Affordable Health Choices Act of 2009 H.R.3590 Patient Protection and Affordable Care Act H.R.3962 Affordable Health Care for America Act H.R.4872 Health Care and Education Reconciliation Act of 2010 H.R.4956 Stop Oxy Abuse Act of 2010 S.301 Physician Payments Sunshine Act of 2009 S.369 Preserve Access to Affordable Generics Act of 2009 S.1796 America's Healthy Future Act of 2009 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar drugs Disposal of drugs Drug reimportation Healthcare reform Hearings related to prescription drug abuse and prevention Patent settlements Pedigree legislation Prescription Drug User Fee Act reauthorization Riskevaluation and mitigationstrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
H.R.756/S.660 National Pain Care Policy Act of 2009 H.R.1191/S. 1336 Safe Drug Disposal Act of 2009 H.R.1260/S.515/S.610 Patent Reform Act of 2009 H.R.1298/S.525 Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 Pathway for Biosimilars Act H.R.1706 Protecting Consumer Access to Generic Drugs Act of 2009 H.R.3200 America's Affordable Health Choices Act of 2009 H.R.3590 Patient Protection and Affordable Care Act H.R.3962 Affordable Health Care for America Act H.R.4872 Health Care and Education Reconciliation Act of 2010 H.R.4956 Stop Oxy Abuse Act of 2010 S.301 Physician Payments Sunshine Act of 2009 S.369 Preserve Access to Affordable Generics Act of 2009 S.1796 America's Healthy Future Act of 2009 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar drugs Disposal of drugs Drug reimportation Healthcare reform Hearings related to prescription drug abuse and prevention Patent settlements Pedigree legislation Prescription Drug User Fee Act reauthorization Riskevaluation and mitigationstrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HR 3200America's Affordable Health Choices Act of 2009 S 1796America's Healthy Future Act of 2009 HR 756National Pain Care Policy Act of 2009 S 660 National Pain Care Policy Act of 2009 HR 1260Patent Reform Act of 2009 S 515 Patent Reform Act of 2009 S 610 Patent Reform Act of 2009 HR 3590Patient Protection and Affordable Care Act HR 1298Pharmaceutical Market Access and Drug Safety Act of 2009 S 525 Pharmaceutical Market Access and Drug Safety Act of 2009 S 301 Physician Payments Sunshine Act of 2009 HR 1427Promoting Innovation and Access to Life-Saving Medicine Act S 726 Promoting Innovation and Access to Life-Saving Medicine Act HR 1706Protecting Consumer Access to Generic Drugs Act of 2009 S 369 Preserve Access to Affordable Generics Act of 2009 HR 1191Safe Drug Disposal Act of 2009 S 1336Safe Drug Disposal Act of 2009 HR 1359Secure and Responsible Drug Disposal Act of 2009 S 1292Secure and Responsible Drug Disposal Act of 2009 Anti- counterfeiting legislation concerning drugs Healthcare Reform Hearings related to prescription drug abuse and prevention Patent Settlements Pedigree Legislation Risk Evaluation and Mitigation Strategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
HR 3200America's Affordable Health Choices Act of 2009 S 1796America's Healthy Future Act of 2009 HR 756National Pain Care Policy Act of 2009 S 660 National Pain Care Policy Act of 2009 HR 1260Patent Reform Act of 2009 S 515 Patent Reform Act of 2009 S 610 Patent Reform Act of 2009 HR 3590Patient Protection and Affordable Care Act HR 1298Pharmaceutical Market Access and Drug Safety Act of 2009 S 525 Pharmaceutical Market Access and Drug Safety Act of 2009 S 301 Physician Payments Sunshine Act of 2009 HR 1427Promoting Innovation and Access to Life-Saving Medicine Act S 726 Promoting Innovation and Access to Life-Saving Medicine Act HR 1706Protecting Consumer Access to Generic Drugs Act of 2009 S 369 Preserve Access to Affordable Generics Act of 2009 HR 1191Safe Drug Disposal Act of 2009 S 1336Safe Drug Disposal Act of 2009 HR 1359Secure and Responsible Drug Disposal Act of 2009 S 1292Secure and Responsible Drug Disposal Act of 2009 Anti- counterfeiting legislation concerning drugs Healthcare Reform Hearings related to prescription drug abuse and prevention Patent Settlements Pedigree Legislation Risk Evaluation and Mitigation Strategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HR 3200America's Affordable Health Choices Act of 2009 HR 756National Pain Care Policy Act of 2009 S 660National Pain Care Policy Act of 2009 HR 1260Patent Reform Act of 2009 S 515Patent Reform Act of 2009 S 610Patent Reform Act of 2009 HR 1548Pathway for Biosimilars Act HR 1298Pharmaceutical Market Access and Drug Safety Act of 2009 S 525Pharmaceutical Market Access and Drug Safety Act of 2009 S 301Physician Payments Sunshine Act of 2009 HR 1427Promoting Innovation and Access to Life-Saving Medicine Act S 726Promoting Innovation and Access to Life-Saving Medicine Act HR 1706Protecting Consumer Access to Generic Drugs Act of 2009 S 369Preserve Access to Affordable Generics Act of 2009 HR 1191Safe Drug Disposal Act of 2009 S 1336Safe Drug Disposal Act of 2009 HR 1359Secure and Responsible Drug Disposal Act of 2009 S 1292Secure and Responsible Drug Disposal Act of 2009 Anti- counterfeiting legislation concerning drugs Healthcare Reform Hearings related to prescription drug abuse and prevention Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
HR 3200America's Affordable Health Choices Act of 2009 HR 756National Pain Care Policy Act of 2009 S 660National Pain Care Policy Act of 2009 HR 1260Patent Reform Act of 2009 S 515Patent Reform Act of 2009 S 610Patent Reform Act of 2009 HR 1548Pathway for Biosimilars Act HR 1298Pharmaceutical Market Access and Drug Safety Act of 2009 S 525Pharmaceutical Market Access and Drug Safety Act of 2009 S 301Physician Payments Sunshine Act of 2009 HR 1427Promoting Innovation and Access to Life-Saving Medicine Act S 726Promoting Innovation and Access to Life-Saving Medicine Act HR 1706Protecting Consumer Access to Generic Drugs Act of 2009 S 369Preserve Access to Affordable Generics Act of 2009 HR 1191Safe Drug Disposal Act of 2009 S 1336Safe Drug Disposal Act of 2009 HR 1359Secure and Responsible Drug Disposal Act of 2009 S 1292Secure and Responsible Drug Disposal Act of 2009 Anti- counterfeiting legislation concerning drugs Healthcare Reform Hearings related to prescription drug abuse and prevention Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
HR 3200America's Affordable Health Choices Act of 2009 HR 756National Pain Care Policy Act of 2009 S 660National Pain Care Policy Act of 2009 HR 1260Patent Reform Act of 2009 S 515Patent Reform Act of 2009 S 610Patent Reform Act of 2009 HR 1548Pathway for Biosimilars Act HR 1298Pharmaceutical Market Access and Drug Safety Act of 2009 S 525Pharmaceutical Market Access and Drug Safety Act of 2009 S 301Physician Payments Sunshine Act of 2009 HR 1427Promoting Innovation and Access to Life-Saving Medicine Act S 726Promoting Innovation and Access to Life-Saving Medicine Act HR 1706Protecting Consumer Access to Generic Drugs Act of 2009 S 369Preserve Access to Affordable Generics Act of 2009 HR 1191Safe Drug Disposal Act of 2009 S 1336Safe Drug Disposal Act of 2009 HR 1359Secure and Responsible Drug Disposal Act of 2009 S 1292Secure and Responsible Drug Disposal Act of 2009 Anti- counterfeiting legislation concerning drugs Healthcare Reform Hearings related to prescription drug abuse and prevention Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
H.R.756 / S.660National Pain Care Policy Act of 2009 H.R.1260 / S/515 / S.610 Patent Reform Act of 2009 S.301 Physician Payments Sunshine Act of 2009 H.R.1706 Protecting Consumer Access to Generic Drugs Act of 2009 S.369 Preserve Access to Affordable Generics Act of 2009 H.R.1191 / S.1336 Safe Drug Disposal Act of 2009 H.R.1359 / S.1292 Secure and Responsible Drug Disposal Act of 2009 Anti- counterfeiting legislation concerding drugs Healthcare Reform Hearings related to prescription drug abuse and prevention Pedigree legislation RiskEvaluation and MitigationStrategies for controlled substances
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
H.R. 756 / S.660 - National Pain Care Policy Act of 2009 H.R. 1260 / S.515 / S.610 - Patent Reform Act of 2009 H.R.1706 - Protecting Consumer Access to Generic Drugs Act of 2009 S.301 - Physician Payments Sunshine Act of 2009 S. 369 - Preserve Access to Affordable Generics Act of 2009 Hearings related to prescription drug abuse and prevention Pedigree legislation.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE